Mehdi Najafzadeh - Publications, H-index & Citations

Mehdi Najafzadeh

ucb

28H指数

118论文数

3.5K被引数

收录论文 60

发表时间

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real-World Data: The INVESTED-Medicare Linkage Study 通过连接随机临床试验与现实世界数据来增强证据生成：INVESTED-Medicare关联研究

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2026-09-07

OAAI

Hanseul Cho; HoJin Shin; Mehdi Najafzadeh; Brian Claggett; Janinne Ortega-Montiel; Jun Liu; Julie M. Paik; Narlina F. Lalani; Marie C. Bradley; John Concato; Scott D. Solomon; Orly Vardeny; Elisabetta Patorno

Linkage of Clinical Trial Data to Routinely Collected Data Sources A Scoping Review 临床 trial 数据与常规收集数据源的关联：一项范围综述

JAMA NETWORK OPEN

IF9.7

2025-04-29

OAAI

NajafZadeh, Mehdi; Oromendia, Ana Fernandez; Burcu, Mehmet; Mcconnochie, Ben; Kim, Ella; Vaccaro, Thomas; Patorno, Elisabetta

Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes

DIABETES CARE

IF16.6

2024-06-25

OAAI

Htoo, Phyo Than; NajafZadeh, Mehdi; Tesfaye, Helen; Schneeweiss, Sebastian; Wexler, Deborah J.; Glynn, Robert J.; Schmedt, Niklas; Deruaz-Luyet, Anouk; Koeneman, Lisette; Paik, Julie M.; Patorno, Elisabetta

High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2023-11-03

PREAI

Najafzadeh, Mehdi; Shin, Hojin; Schneeweiss, Sebastian; Wang, Shirley V.; Solomon, Scott D.; Vardeny, Orly; Patorno, Elisabetta

Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2023-07-14

OAAI

Shin, HoJin; Wang, Shirley V.; Kim, Dae Hyun; Alt, Ethan; Mahesri, Mufaddal; Bessette, Lily G.; Schneeweiss, Sebastian; Najafzadeh, Mehdi

Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2023-06-24

PREAI

Sison, Stephanie Denise M.; Lin, Kueiyu Joshua; Najafzadeh, Mehdi; Ko, Darae; Patorno, Elisabetta; Bessette, Lily G.; Zakoul, Heidi; Kim, Dae Hyun

Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

DIABETES OBESITY & METABOLISM

IF5.7

2021-12-01

OAAI

Patorno, Elisabetta; Pawar, Ajinkya; Wexler, Deborah J.; Glynn, Robert J.; Bessette, Lily G.; Paik, Julie M.; Najafzadeh, Mehdi; Brodovicz, Kimberly G.; Deruaz-Luyet, Anouk; Schneeweiss, Sebastian

Cost to Medicare of Delayed Adalimumab Biosimilar Availability

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2021-07-06

PREAI

Lee, ChangWon C.; Najafzadeh, Mehdi; Kesselheim, Aaron S.; Sarpatwari, Ameet

Cardiovascular Effectiveness of Empagliflozin in Patients with and without Cardiovascular Disease

DIABETES

IF7.5

2021-06-01

PREAI

Patorno, Elisabetta; Tesfaye, Helen; Wexler, Deborah J.; Glynn, Robert; Najafzadeh, Mehdi; Bessette, Lily G.; Zabotka, Luke; Koeneman, Lisette; Deruaz-Luyet, Anouk; Schneeweiss, Sebastian

Comparative Safety of Empagliflozin in Routine Care Patients: Interim Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

DIABETES

IF7.5

2021-06-01

PREAI

Patorno, Elisabetta; Tesfaye, Helen; Wexler, Deborah J.; Glynn, Robert; Najafzadeh, Mehdi; Bessette, Lily G.; Zakoul, Heidi; Koeneman, Lisette; Deruaz-Luyet, Anouk; Schneeweiss, Sebastian

Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition Unclear

HEALTH AFFAIRS

IF8.1

2021-05-01

PREAI

Sarpatwari, Ameet; Tessema, Frazer A.; Zakarian, Marie; Najafzadeh, Mehdi N.; Kesselheim, Aaron S.

Restricted mean survival time versus conventional measures for treatment decision-making

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2021-04-26

OAAI

Kim, Dae Hyun; Shi, Sandra M.; Carroll, Danette; Najafzadeh, Mehdi; Wei, Lee-Jen

Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984-2018: an evaluation of Food and Drug Administration flexibilities

LANCET INFECTIOUS DISEASES

IF31

2020-07-01

PREAI

Darrow, Jonathan J.; Najafzadeh, Mehdi; Stefanini, Kristina; Kesselheim, Aaron S.

Effectiveness and Safety of Empagliflozin in Routine Care Patients: Interim Results from the EMPagliflozin compaRative effectiveness and SafEty (EMPRISE) Study

DIABETES

IF7.5

2020-06-01

PREAI

Patorno, Elisabetta; Pawar, Ajinkya; Bessette, Lily G.; Franklin, Jessica; Najafzadeh, Mehdi; Wexler, Deborah J.; Deruaz-Luyet, Anouk; Brodovicz, Kimberly; Schneeweiss, Sebastian

Cardiovascular Outcomes in Older Adults Initiating Empagliflozin vs. DPP-4 Inhibitors and GLP-1 Receptor Agonists: A Subgroup Analysis from the EMPRISE Study

DIABETES

IF7.5

2020-06-01

PREAI

Patorno, Elisabetta; Pawar, Ajinkya; Bessette, Lily G.; Najafzadeh, Mehdi; Wexler, Deborah J.; Franklin, Jessica; Deruaz-Luyet, Anouk; Brodovicz, Kimberly; Koeneman, Lisette; Schneeweiss, Sebastian

Parental Considerations Regarding Cure and Late Effects for Children With Cancer

PEDIATRICS

IF6.4

2020-04-13

OAAI

Greenzang, Katie A.; Al-Sayegh, Hasan; Ma, Clement; Najafzadeh, Mehdi; Wittenberg, Eve; Mack, Jennifer W.

Empagliflozin selected cardiovascular and safety outcomes in routine care: First results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2020-03-01

PREAI

Patorno, E.; Pawar, A.; Franklin, J. M.; Najafzadeh, M.; Deruaz-Luyet, A.; Brodovicz, K. G.; Sambevski, S.; Bessette, L. G.; Kulldorff, M.; Schneeweiss, S.

Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2019-07-17

OAAI

Li, David G.; Najafzadeh, Mehdi; Kesselheim, Aaron S.; Mostaghimi, Arash

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care A First Analysis From the EMPRISE Study

CIRCULATION

IF38.6

2019-06-18

167

OAAI

Patorno, Elisabetta; Pawar, Ajinkya; Franklin, Jessica M.; Najafzadeh, Mehdi; Deruaz-Luyet, Anouk; Brodovicz, Kimberly G.; Sambevski, Steven; Bessette, Lily G.; Ortiz, Adrian J. Santiago; Kulldorff, Martin; Schneeweiss, Sebastian

Empagliflozin Selected Cardiovascular and Safety Outcomes in Routine Care: First Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

DIABETES

IF7.5

2019-06-01

PREAI

Patorno, Elisabetta; Pawar, Ajinkya; Franklin, Jessica; Najafzadeh, Mehdi; Deruaz-Luyet, Anouk; Brodovicz, Kimberly; Sambevski, Steven; Bessette, Lily G.; Kulldorff, Martin; Schneeweiss, Sebastian

研究方向